2013

Perrigo names board of directors

Friday, December 20, 2013

Dublin, Ireland-based Perrigo has announced the appointment of its board of directors, effective until Perrigo’s annual general meeting scheduled for November 2014. The appointment of the Perrigo board follows the completion of Perrigo’s acquisition of Elan in a cash and stock transaction valued at approximately $8.6 billion. The transaction will create a global healthcare company with a growth profile.

[Read More]

Bayer to acquire Algeta

Friday, December 20, 2013

Bayer, through Aviator Acquisition, a wholly-owned subsidiary of Bayer Nordic, will launch a voluntary offer to acquire Algeta for $58.7 per share in cash, for a total value of approximately $2.9 billion. Algeta’s board of directors has unanimously decided to recommend its shareholders accept the offer.

[Read More]

PCORI approves $191 million for patient-centered comparative effectiveness research

Wednesday, December 18, 2013

The independent, nonprofit Patient-Centered Outcomes Research Institute (PCORI) has approved a total of $97.3 million in new funding for 53 comparative effectiveness research (CER) studies designed to answer questions important to patients and those who care for them. It also has approved $93.5 million to build and expand the individual research data networks that will form PCORnet, a new, national, patient-centered clinical research network to facilitate CER.

[Read More]

Endo to acquire NuPathe

Wednesday, December 18, 2013

Endo Health Solutions, a U.S.-based specialty healthcare company, has entered into a definitive agreement to acquire NuPathe, a specialty pharmaceutical company focused on neuroscience solutions for central nervous system diseases, for $2.85 per share in cash, or approximately $105 million. 

[Read More]